The Impact prognosis of penile cancer patients after laparoscopic inguinal lymph node dissection with or without saphenous vein preservation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039139

Enrollment

Unknown

Registered

2020-10-19

Start date

2016-12-01

Completion date

Unknown

Last updated

2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penile cancer

Interventions

Saphenous vein preservation group:Preserve saphenous vein

No saphenous vein preservation group:No preserve saphenous vein

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Penile cancer patients, age <=85 years old, penile tumors <=T3N2M0.

Exclusion criteria

Exclusion criteria: Deep venous thrombosis of the lower extremities, severe heart, lung, and brain diseases that cannot tolerate surgery.

Design outcomes

Primary

Measure	Time frame
Number of lymph nodes removed;	—

Secondary

Measure	Time frame
Lymphedema of lower limbs;Scrotal edema;Lymph node recurrence;Pelvic lymph node metastasis;Intraoperative and postoperative bleeding;	—

Countries

China

Contacts

Public ContactLu Mujun

Renji Hospital, Shanghai Jiaotong University School of Medicine

lumujun@163.com+86 13020156427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026